Amgen shares top $100 as fears fade over biosimilars | Pacific Coast Business Times

PPB

Montecito

Nixon Peabody

SBCC

BOL

Bank of America

Loading...

You are here: Home > Banking & Finance > Current Article

Amgen shares top $100 as fears fade over biosimilars

By Stephen Nellis / Friday, April 5th, 2013 / Comments Off on Amgen shares top $100 as fears fade over biosimilars

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.

NEXT ARTICLE →
Up in the air: When it makes sense to take your small business into the cloud

← PREVIOUS ARTICLE
Green Coast 2013: How the region is leading the way in energy efficiency

About the author

Stephen Nellis

Senior editor

View all articles by Stephen Nellis »

Related Articles

Thursday, April 25th, 2019

Teledyne reports record first quarter earnings but stock falls

Friday, April 19th, 2019

Military leaders are good choices for president

Friday, April 19th, 2019

Former J.D. Power building revamped, re-branded Gate One

You might also like...

Citizens Business Bank parent beats analysts’ earnings expectations